Comprehensive Immunological Tumor Map - IHC Interpretation and Consultation (14 Markers)

A high-level strategic consulting package focuses on creating a comprehensive immuno-biological map of the tumor. This includes integrated and interrelated analysis of fourteen immunohistochemical (IHC) markers, broadly covering diagnostic, prognostic, and therapeutic domains. Interactions between multiple pathways are analyzed (e.g., HIF-1α for hypoxia response, LAG-3 for immunity, TS for chemotherapy response). The package is reviewed by an Advanced Treatment Planning Committee comprising an oncologist, pathologist, clinical pharmacist, and radiation therapist. The goal is to generate a multi-pronged treatment blueprint based on the tumor's biological strengths and weaknesses.